These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8319266)

  • 1. Action of tolytoxin on cell morphology, cytoskeletal organization, and actin polymerization.
    Patterson GM; Smith CD; Kimura LH; Britton BA; Carmeli S
    Cell Motil Cytoskeleton; 1993; 24(1):39-48. PubMed ID: 8319266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance.
    Smith CD; Carmeli S; Moore RE; Patterson GM
    Cancer Res; 1993 Mar; 53(6):1343-7. PubMed ID: 8095179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the actin polymerization status as an apoptotic morphological effector in HL-60 cells.
    Rao JY; Jin YS; Zheng Q; Cheng J; Tai J; Hemstreet GP
    J Cell Biochem; 1999 Dec; 75(4):686-97. PubMed ID: 10572251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of protrusion by neomycin in human glioma cells is correlated with a decrease followed by an increase in filamentous actin.
    Safiejko-Mroczka B; Bell PB
    Cell Biol Int; 1995 Aug; 19(8):655-74. PubMed ID: 7550074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermia effects on the cytoskeleton and on cell morphology.
    Coakley WT
    Symp Soc Exp Biol; 1987; 41():187-211. PubMed ID: 3332484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells.
    Dirks PB; Patel K; Hubbard SL; Ackerley C; Hamel PA; Rutka JT
    Oncogene; 1997 Oct; 15(17):2037-48. PubMed ID: 9366521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular factors mediate cadmium-dependent actin depolymerization.
    Wang Z; Templeton DM
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):115-21. PubMed ID: 8685893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of actin filaments and microtubules in hepatocyte spheroid self-assembly.
    Tzanakakis ES; Hansen LK; Hu WS
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):175-89. PubMed ID: 11223949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfilament depletion and circumvention of multiple drug resistance by sphinxolides.
    Zhang X; Minale L; Zampella A; Smith CD
    Cancer Res; 1997 Sep; 57(17):3751-8. PubMed ID: 9288783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-independent effects of cadmium on actin assembly in mesangial and vascular smooth muscle cells.
    Wang Z; Chin TA; Templeton DM
    Cell Motil Cytoskeleton; 1996; 33(3):208-22. PubMed ID: 8674140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in cytoskeletal actin content, F-actin distribution, and surface morphology during HL-60 cell volume regulation.
    Hallows KR; Law FY; Packman CH; Knauf PA
    J Cell Physiol; 1996 Apr; 167(1):60-71. PubMed ID: 8698841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton.
    Hayot C; Farinelle S; De Decker R; Decaestecker C; Darro F; Kiss R; Van Damme M
    Int J Oncol; 2002 Aug; 21(2):417-25. PubMed ID: 12118340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with actin dynamics is superior to disturbance of microtubule function in the inhibition of human ovarian cancer cell motility.
    Bijman MN; van Berkel MP; van Nieuw Amerongen GP; Boven E
    Biochem Pharmacol; 2008 Sep; 76(6):707-16. PubMed ID: 18644348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hurghadolide A and swinholide I, potent actin-microfilament disrupters from the Red Sea sponge Theonella swinhoei.
    Youssef DT; Mooberry SL
    J Nat Prod; 2006 Jan; 69(1):154-7. PubMed ID: 16441091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor.
    Hamdi HK; Castellon R
    Biochem Biophys Res Commun; 2005 Sep; 334(3):769-78. PubMed ID: 16024000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoskeletal organization and cell motility correlates with metastatic potential and state of differentiation in prostate cancer.
    Donald CD; Cooper CR; Harris-Hooker S; Emmett N; Scanlon M; Cooke DB
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1033-8. PubMed ID: 11785653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxins affecting actin filaments and microtubules.
    Saito SY
    Prog Mol Subcell Biol; 2009; 46():187-219. PubMed ID: 19184589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the cytoskeleton in regulation of collagen synthesis and secretion.
    Carinci P; Bodo M; Evangelisti R; Becchetti E
    Ital J Anat Embryol; 1995; 100 Suppl 1():65-74. PubMed ID: 11322343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gap junctions assemble in the presence of cytoskeletal inhibitors, but enhanced assembly requires microtubules.
    Johnson RG; Meyer RA; Li XR; Preus DM; Tan L; Grunenwald H; Paulson AF; Laird DW; Sheridan JD
    Exp Cell Res; 2002 Apr; 275(1):67-80. PubMed ID: 11925106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells.
    Motomura W; Nagamine M; Tanno S; Sawamukai M; Takahashi N; Kohgo Y; Okumura T
    J Gastroenterol; 2004; 39(5):461-8. PubMed ID: 15175945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.